Inflammation marker may guide prognosis for prostate cancer
Wednesday, September 28, 2011 - 08:01
in Health & Medicine
(Medical Xpress) -- Current methods of prostate cancer detection, like the prostate-specific antigen (PSA) test, often fail to identify which cancers will prove fatal and which cancers will remain benign until a patient dies of other causes.